Annual D&A
$530.00 K
-$91.00 K-14.65%
December 31, 2023
Summary
- As of February 8, 2025, KPTI annual depreciation & amortization is $530.00 thousand, with the most recent change of -$91.00 thousand (-14.65%) on December 31, 2023.
- During the last 3 years, KPTI annual D&A has fallen by -$442.00 thousand (-45.47%).
- KPTI annual D&A is now -45.59% below its all-time high of $974.00 thousand, reached on December 31, 2019.
Performance
KPTI Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$83.00 K
-$8000.00-8.79%
September 30, 2024
Summary
- As of February 8, 2025, KPTI quarterly depreciation & amortization is $83.00 thousand, with the most recent change of -$8000.00 (-8.79%) on September 30, 2024.
- Over the past year, KPTI quarterly D&A has dropped by -$8000.00 (-8.79%).
- KPTI quarterly D&A is now -71.38% below its all-time high of $290.00 thousand, reached on March 31, 2023.
Performance
KPTI Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$336.00 K
+$3000.00+0.90%
September 30, 2024
Summary
- As of February 8, 2025, KPTI TTM depreciation & amortization is $336.00 thousand, with the most recent change of +$3000.00 (+0.90%) on September 30, 2024.
- Over the past year, KPTI TTM D&A has increased by +$3000.00 (+0.90%).
- KPTI TTM D&A is now -65.50% below its all-time high of $974.00 thousand, reached on December 31, 2019.
Performance
KPTI TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
KPTI Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.7% | -8.8% | +0.9% |
| 3 y3 years | -45.5% | -55.4% | -63.0% |
| 5 y5 years | -27.9% | -65.8% | -65.5% |
KPTI Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -32.8% | at low | -71.4% | +7.8% | -57.4% | +3.4% |
| 5 y | 5-year | -45.6% | at low | -71.4% | +7.8% | -65.5% | +3.4% |
| alltime | all time | -45.6% | +538.5% | -71.4% | +144.1% | -65.5% | +888.2% |
Karyopharm Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $83.00 K(-8.8%) | $336.00 K(+0.9%) |
| Jun 2024 | - | $91.00 K(+7.1%) | $333.00 K(+2.5%) |
| Mar 2024 | - | $85.00 K(+10.4%) | $325.00 K(-38.7%) |
| Dec 2023 | $530.00 K(-14.7%) | $77.00 K(-3.8%) | $530.00 K(-6.4%) |
| Sep 2023 | - | $80.00 K(-3.6%) | $566.00 K(-15.3%) |
| Jun 2023 | - | $83.00 K(-71.4%) | $668.00 K(-9.0%) |
| Mar 2023 | - | $290.00 K(+156.6%) | $734.00 K(+18.2%) |
| Dec 2022 | $621.00 K(-21.3%) | $113.00 K(-37.9%) | $621.00 K(-4.0%) |
| Sep 2022 | - | $182.00 K(+22.1%) | $647.00 K(-0.6%) |
| Jun 2022 | - | $149.00 K(-15.8%) | $651.00 K(-10.9%) |
| Mar 2022 | - | $177.00 K(+27.3%) | $731.00 K(-7.4%) |
| Dec 2021 | $789.00 K(-18.8%) | $139.00 K(-25.3%) | $789.00 K(-13.0%) |
| Sep 2021 | - | $186.00 K(-18.8%) | $907.00 K(-5.1%) |
| Jun 2021 | - | $229.00 K(-2.6%) | $956.00 K(-0.9%) |
| Mar 2021 | - | $235.00 K(-8.6%) | $965.00 K(-0.7%) |
| Dec 2020 | $972.00 K(-0.2%) | $257.00 K(+9.4%) | $972.00 K(+1.4%) |
| Sep 2020 | - | $235.00 K(-1.3%) | $959.00 K(-0.8%) |
| Jun 2020 | - | $238.00 K(-1.7%) | $967.00 K(-0.4%) |
| Mar 2020 | - | $242.00 K(-0.8%) | $971.00 K(-0.3%) |
| Dec 2019 | $974.00 K(+32.5%) | $244.00 K(+0.4%) | $974.00 K(+5.4%) |
| Sep 2019 | - | $243.00 K(+0.4%) | $924.00 K(+6.3%) |
| Jun 2019 | - | $242.00 K(-1.2%) | $869.00 K(+7.2%) |
| Mar 2019 | - | $245.00 K(+26.3%) | $811.00 K(+10.3%) |
| Dec 2018 | $735.00 K | $194.00 K(+3.2%) | $735.00 K(+2.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $188.00 K(+2.2%) | $715.00 K(+1.7%) |
| Jun 2018 | - | $184.00 K(+8.9%) | $703.00 K(+0.6%) |
| Mar 2018 | - | $169.00 K(-2.9%) | $699.00 K(-2.0%) |
| Dec 2017 | $713.00 K(-0.6%) | $174.00 K(-1.1%) | $713.00 K(-0.8%) |
| Sep 2017 | - | $176.00 K(-2.2%) | $719.00 K(-0.4%) |
| Jun 2017 | - | $180.00 K(-1.6%) | $722.00 K(+0.1%) |
| Mar 2017 | - | $183.00 K(+1.7%) | $721.00 K(+0.6%) |
| Dec 2016 | $717.00 K(+13.1%) | $180.00 K(+0.6%) | $717.00 K(+0.4%) |
| Sep 2016 | - | $179.00 K(0.0%) | $714.00 K(+2.0%) |
| Jun 2016 | - | $179.00 K(0.0%) | $700.00 K(+3.4%) |
| Mar 2016 | - | $179.00 K(+1.1%) | $677.00 K(+6.8%) |
| Dec 2015 | $634.00 K(+96.3%) | $177.00 K(+7.3%) | $634.00 K(+7.6%) |
| Sep 2015 | - | $165.00 K(+5.8%) | $589.00 K(+11.1%) |
| Jun 2015 | - | $156.00 K(+14.7%) | $530.00 K(+27.4%) |
| Mar 2015 | - | $136.00 K(+3.0%) | $416.00 K(+28.8%) |
| Dec 2014 | $323.00 K(+124.3%) | $132.00 K(+24.5%) | $323.00 K(+41.0%) |
| Sep 2014 | - | $106.00 K(+152.4%) | $229.00 K(+43.1%) |
| Jun 2014 | - | $42.00 K(-2.3%) | $160.00 K(+4.6%) |
| Mar 2014 | - | $43.00 K(+13.2%) | $153.00 K(+6.3%) |
| Dec 2013 | $144.00 K(+18.0%) | $38.00 K(+2.7%) | $144.00 K(+35.8%) |
| Sep 2013 | - | $37.00 K(+5.7%) | $106.00 K(+53.6%) |
| Jun 2013 | - | $35.00 K(+2.9%) | $69.00 K(+102.9%) |
| Mar 2013 | - | $34.00 K | $34.00 K |
| Dec 2012 | $122.00 K(+47.0%) | - | - |
| Dec 2011 | $83.00 K | - | - |
FAQ
- What is Karyopharm Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics annual D&A year-on-year change?
- What is Karyopharm Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly D&A year-on-year change?
- What is Karyopharm Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics TTM D&A year-on-year change?
What is Karyopharm Therapeutics annual depreciation & amortization?
The current annual D&A of KPTI is $530.00 K
What is the all time high annual D&A for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual depreciation & amortization is $974.00 K
What is Karyopharm Therapeutics annual D&A year-on-year change?
Over the past year, KPTI annual depreciation & amortization has changed by -$91.00 K (-14.65%)
What is Karyopharm Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of KPTI is $83.00 K
What is the all time high quarterly D&A for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly depreciation & amortization is $290.00 K
What is Karyopharm Therapeutics quarterly D&A year-on-year change?
Over the past year, KPTI quarterly depreciation & amortization has changed by -$8000.00 (-8.79%)
What is Karyopharm Therapeutics TTM depreciation & amortization?
The current TTM D&A of KPTI is $336.00 K
What is the all time high TTM D&A for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high TTM depreciation & amortization is $974.00 K
What is Karyopharm Therapeutics TTM D&A year-on-year change?
Over the past year, KPTI TTM depreciation & amortization has changed by +$3000.00 (+0.90%)